SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-016685
Filing Date
2020-08-05
Accepted
2020-08-05 16:33:29
Documents
6
Period of Report
2020-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20200804_8k.htm 8-K 31713
2 EXHIBIT 99.1 ex_197299.htm EX-99.1 11440
3 EXHIBIT 99.2 ex_197300.htm EX-99.2 60964
4 EXHIBIT 99.3 ex_197301.htm EX-99.3 45531
5 ex_197300img001.gif GRAPHIC 14754
6 g1.jpg GRAPHIC 47885
  Complete submission text file 0001437749-20-016685.txt   237392
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 201078111
SIC: 2834 Pharmaceutical Preparations